Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Cost saving of switching to equivalent inhalers and its effect on health outcomes.

Bloom CI, Douglas I, Olney J, D'Ancona G, Smeeth L, Quint JK.

Thorax. 2019 Aug 5. pii: thoraxjnl-2018-212957. doi: 10.1136/thoraxjnl-2018-212957. [Epub ahead of print]

PMID:
31383774
2.

Corrigendum to "A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains" [Vaccine 37 (2019) 2369-2376].

Ross TM, DiNapoli J, Giel-Moloney M, Bloom CE, Bertran K, Balzli C, Strugnell T, Oomen RP, Sá E Silva M, Mebatsion T, Bublot M, Swayne DE, Kleanthous H.

Vaccine. 2019 Sep 3;37(37):5664. doi: 10.1016/j.vaccine.2019.07.058. Epub 2019 Aug 2. No abstract available.

PMID:
31383487
3.

Clinical pharmacy specialists' impact in patient aligned care teams for type 2 diabetes management.

Bloom CI, Ku M, Williams M.

J Am Pharm Assoc (2003). 2019 Jun 13. pii: S1544-3191(19)30221-3. doi: 10.1016/j.japh.2019.05.002. [Epub ahead of print]

PMID:
31204200
4.

Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care.

Bloom CI, Ricciardi F, Smeeth L, Stone P, Quint JK.

BMC Med. 2019 Apr 5;17(1):73. doi: 10.1186/s12916-019-1310-0.

5.

A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains.

Ross TM, DiNapoli J, Giel-Moloney M, Bloom CE, Bertran K, Balzli C, Strugnell T, Sá E Silva M, Mebatsion T, Bublot M, Swayne DE, Kleanthous H.

Vaccine. 2019 Apr 17;37(17):2369-2376. doi: 10.1016/j.vaccine.2019.03.018. Epub 2019 Mar 21. Erratum in: Vaccine. 2019 Sep 3;37(37):5664.

PMID:
30905528
6.

Optimizing the clinical utility of four proposed criteria for a persistent and impairing grief disorder by emphasizing core, rather than associated symptoms.

Cozza SJ, Shear MK, Reynolds CF, Fisher JE, Zhou J, Maercker A, Simon N, Mauro C, Skritskaya N, Zisook S, Lebowitz B, Bloom CG, Fullerton CS, Ursano RJ.

Psychol Med. 2019 Mar 4:1-8. doi: 10.1017/S0033291719000254. [Epub ahead of print]

PMID:
30829195
7.

Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016.

Bloom CI, Elkin SL, Quint JK.

Int J Chron Obstruct Pulmon Dis. 2019 Jan 22;14:279-287. doi: 10.2147/COPD.S190086. eCollection 2019.

8.

Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006-2016.

Bloom CI, Saglani S, Feary J, Jarvis D, Quint JK.

Eur Respir J. 2019 Apr 4;53(4). pii: 1802130. doi: 10.1183/13993003.02130-2018. Print 2019 Apr.

PMID:
30765507
9.

Author Correction: Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza.

Dunning J, Blankley S, Hoang LT, Cox M, Graham CM, James PL, Bloom CI, Chaussabel D, Banchereau J, Brett SJ; MOSAIC Investigators, Moffatt MF, O'Garra A, Openshaw PJM.

Nat Immunol. 2019 Mar;20(3):373. doi: 10.1038/s41590-019-0328-y.

10.

Changing causes of death for patients with chronic respiratory disease in England, 2005-2015.

Gayle AV, Axson EL, Bloom CI, Navaratnam V, Quint JK.

Thorax. 2019 May;74(5):483-491. doi: 10.1136/thoraxjnl-2018-212514. Epub 2019 Jan 29.

PMID:
30696745
11.

Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink).

Nissen F, Douglas IJ, Müllerová H, Pearce N, Bloom CI, Smeeth L, Quint JK.

J Asthma Allergy. 2019 Jan 8;12:7-19. doi: 10.2147/JAA.S182013. eCollection 2019.

12.

Exacerbation Patterns in Adults with Asthma in England. A Population-based Study.

Bloom CI, Palmer T, Feary J, Quint JK, Cullinan P.

Am J Respir Crit Care Med. 2019 Feb 15;199(4):446-453. doi: 10.1164/rccm.201808-1516OC.

PMID:
30507307
13.

Risk factors and secondary care utilisation in a primary care population with non-tuberculous mycobacterial disease in the UK.

Axson EL, Bual N, Bloom CI, Quint JK.

Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):117-124. doi: 10.1007/s10096-018-3402-8. Epub 2018 Oct 27.

14.

The 2015 landslide and tsunami in Taan Fiord, Alaska.

Higman B, Shugar DH, Stark CP, Ekström G, Koppes MN, Lynett P, Dufresne A, Haeussler PJ, Geertsema M, Gulick S, Mattox A, Venditti JG, Walton MAL, McCall N, Mckittrick E, MacInnes B, Bilderback EL, Tang H, Willis MJ, Richmond B, Reece RS, Larsen C, Olson B, Capra J, Ayca A, Bloom C, Williams H, Bonno D, Weiss R, Keen A, Skanavis V, Loso M.

Sci Rep. 2018 Sep 6;8(1):12993. doi: 10.1038/s41598-018-30475-w.

15.

Hospitalisation and mortality outcomes of patients with comorbid COPD and heart failure: a systematic review protocol.

Axson EL, Sundaram V, Bloom CI, Bottle A, Cowie MR, Quint JK.

BMJ Open. 2018 Jun 30;8(6):e023058. doi: 10.1136/bmjopen-2018-023058.

16.

Nontuberculous mycobacterial disease managed within UK primary care, 2006-2016.

Axson EL, Bloom CI, Quint JK.

Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1795-1803. doi: 10.1007/s10096-018-3315-6. Epub 2018 Jun 27.

17.

Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza.

Dunning J, Blankley S, Hoang LT, Cox M, Graham CM, James PL, Bloom CI, Chaussabel D, Banchereau J, Brett SJ, Moffatt MF, O'Garra A, Openshaw PJM; MOSAIC Investigators.

Nat Immunol. 2018 Jun;19(6):625-635. doi: 10.1038/s41590-018-0111-5. Epub 2018 May 18. Erratum in: Nat Immunol. 2019 Mar;20(3):373.

18.

Low uptake of palliative care for COPD patients within primary care in the UK.

Bloom CI, Slaich B, Morales DR, Smeeth L, Stone P, Quint JK.

Eur Respir J. 2018 Feb 14;51(2). pii: 1701879. doi: 10.1183/13993003.01879-2017. Print 2018 Feb.

19.
20.

Exacerbation risk and characterisation of the UK's asthma population from infants to old age.

Bloom CI, Nissen F, Douglas IJ, Smeeth L, Cullinan P, Quint JK.

Thorax. 2018 Apr;73(4):313-320. doi: 10.1136/thoraxjnl-2017-210650. Epub 2017 Oct 26.

21.

Thinking outside the lungs: 'other' risk factors for pneumonia hospitalisation.

Bloom CI, Quint JK.

Thorax. 2017 Jul;72(7):596-597. doi: 10.1136/thoraxjnl-2016-209773. Epub 2017 Mar 7. No abstract available.

PMID:
28270535
22.

A qualitative study of patient and provider perspectives on using web-based pain coping skills training to treat persistent cancer pain.

Rini C, Vu MB, Lerner H, Bloom C, Carda-Auten J, Wood WA, Basch EM, Voorhees PM, Reeder-Hayes KE, Keefe FJ.

Palliat Support Care. 2018 Apr;16(2):155-169. doi: 10.1017/S1478951517000086. Epub 2017 Mar 7.

PMID:
28264744
23.

Patient experiences of acute myeloid leukemia: A qualitative study about diagnosis, illness understanding, and treatment decision-making.

LeBlanc TW, Fish LJ, Bloom CT, El-Jawahri A, Davis DM, Locke SC, Steinhauser KE, Pollak KI.

Psychooncology. 2017 Dec;26(12):2063-2068. doi: 10.1002/pon.4309. Epub 2016 Dec 19.

PMID:
27862591
24.

The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis.

Blankley S, Graham CM, Turner J, Berry MP, Bloom CI, Xu Z, Pascual V, Banchereau J, Chaussabel D, Breen R, Santis G, Blankenship DM, Lipman M, O'Garra A.

PLoS One. 2016 Oct 5;11(10):e0162220. doi: 10.1371/journal.pone.0162220. eCollection 2016.

25.

A 380-gene meta-signature of active tuberculosis compared with healthy controls.

Blankley S, Graham CM, Levin J, Turner J, Berry MP, Bloom CI, Xu Z, Pascual V, Banchereau J, Chaussabel D, Breen R, Santis G, Blankenship DM, Lipman M, O'Garra A.

Eur Respir J. 2016 Jun;47(6):1873-6. doi: 10.1183/13993003.02121-2015. Epub 2016 Apr 13. No abstract available.

26.

HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling.

Lai RPJ, Meintjes G, Wilkinson KA, Graham CM, Marais S, Van der Plas H, Deffur A, Schutz C, Bloom C, Munagala I, Anguiano E, Goliath R, Maartens G, Banchereau J, Chaussabel D, O'Garra A, Wilkinson RJ.

Nat Commun. 2015 Sep 24;6:8451. doi: 10.1038/ncomms9451.

27.

Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.

Beljanski V, Chiang C, Kirchenbaum GA, Olagnier D, Bloom CE, Wong T, Haddad EK, Trautmann L, Ross TM, Hiscott J.

J Virol. 2015 Oct;89(20):10612-24. doi: 10.1128/JVI.01526-15. Epub 2015 Aug 12.

28.

Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine.

Carter DM, Bloom CE, Kirchenbaum GA, Tsvetnitsky V, Isakova-Sivak I, Rudenko L, Ross TM.

Vaccine. 2015 Jan 1;33(1):108-16. doi: 10.1016/j.vaccine.2014.11.008. Epub 2014 Nov 18.

PMID:
25448100
29.

ET-1 increases reactive oxygen species following hypoxia and high-salt diet in the mouse glomerulus.

Heimlich JB, Speed JS, Bloom CJ, O'Connor PM, Pollock JS, Pollock DM.

Acta Physiol (Oxf). 2015 Mar;213(3):722-30. doi: 10.1111/apha.12397. Epub 2014 Sep 29.

30.

Identification of the key differential transcriptional responses of human whole blood following TLR2 or TLR4 ligation in-vitro.

Blankley S, Graham CM, Howes A, Bloom CI, Berry MP, Chaussabel D, Pascual V, Banchereau J, Lipman M, O'Garra A.

PLoS One. 2014 May 19;9(5):e97702. doi: 10.1371/journal.pone.0097702. eCollection 2014.

31.

The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis.

Blankley S, Berry MP, Graham CM, Bloom CI, Lipman M, O'Garra A.

Philos Trans R Soc Lond B Biol Sci. 2014 May 12;369(1645):20130427. doi: 10.1098/rstb.2013.0427. Print 2014. Review.

32.

Effects of juvenile exposure to predator odor on adolescent and adult anxiety and pain nociception.

Post RJ, Dahlborg KM, O'Loughlin LE, Bloom CM.

Physiol Behav. 2014 May 28;131:57-61. doi: 10.1016/j.physbeh.2014.04.009. Epub 2014 Apr 13.

33.

Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age.

Ross TM, Lin CJ, Nowalk MP, Huang HH, Spencer SM, Shay DK, Sambhara S, Sundaram ME, Friedrich T, Sauereisen S, Bloom CE, Zimmerman RK.

Hum Vaccin Immunother. 2014;10(5):1195-203. doi: 10.4161/hv.28313. Epub 2014 Mar 10.

34.

Feline diabetes mellitus: clinical use of long-acting glargine and detemir.

Bloom CA, Rand J.

J Feline Med Surg. 2014 Mar;16(3):205-15. doi: 10.1177/1098612X14523187. Review.

PMID:
24563492
35.

A novel nonhuman primate model for influenza transmission.

Moncla LH, Ross TM, Dinis JM, Weinfurter JT, Mortimer TD, Schultz-Darken N, Brunner K, Capuano SV 3rd, Boettcher C, Post J, Johnson M, Bloom CE, Weiler AM, Friedrich TC.

PLoS One. 2013 Nov 14;8(11):e78750. doi: 10.1371/journal.pone.0078750. eCollection 2013.

36.

Face to face versus Facebook: does exposure to social networking web sites augment or attenuate physiological arousal among the socially anxious?

Rauch SM, Strobel C, Bella M, Odachowski Z, Bloom C.

Cyberpsychol Behav Soc Netw. 2014 Mar;17(3):187-90. doi: 10.1089/cyber.2012.0498. Epub 2013 Nov 1.

PMID:
24180223
37.

Systems approaches to studying the immune response in tuberculosis.

Berry MP, Blankley S, Graham CM, Bloom CI, O'Garra A.

Curr Opin Immunol. 2013 Oct;25(5):579-87. doi: 10.1016/j.coi.2013.08.003. Epub 2013 Sep 7. Review.

PMID:
24021227
38.

A discriminated conditioned punishment model of phobia.

Bloom CM, Post RJ, Mazick J, Blumenthal B, Doyle C, Peters B, Dyche J, Davenport DG.

Neuropsychiatr Dis Treat. 2013;9:1239-48. doi: 10.2147/NDT.S49886. Epub 2013 Aug 21.

39.

Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers.

Bloom CI, Graham CM, Berry MP, Rozakeas F, Redford PS, Wang Y, Xu Z, Wilkinson KA, Wilkinson RJ, Kendrick Y, Devouassoux G, Ferry T, Miyara M, Bouvry D, Valeyre D, Gorochov G, Blankenship D, Saadatian M, Vanhems P, Beynon H, Vancheeswaran R, Wickremasinghe M, Chaussabel D, Banchereau J, Pascual V, Ho LP, Lipman M, O'Garra A.

PLoS One. 2013 Aug 5;8(8):e70630. doi: 10.1371/journal.pone.0070630. Print 2013. Erratum in: PLoS One. 2013;8(8).doi: 10.1371/annotation/7d9ec449-aee0-48fe-8111-0c110850c0c1. Dominique, Valeyre [corrected to Valeyre, Dominique].

40.

Behavioral assessment of visual deficits in the taiep mutant.

Bloom CM, Post RJ, Anch AM, Davenport DG.

Degener Neurol Neuromuscul Dis. 2013 May 9;3:15-21. doi: 10.2147/DNND.S44064. eCollection 2013.

41.

Diabetes and the kidney in human and veterinary medicine.

Bloom CA, Rand JS.

Vet Clin North Am Small Anim Pract. 2013 Mar;43(2):351-65. doi: 10.1016/j.cvsm.2012.11.002. Review.

PMID:
23522176
42.

The immune response in tuberculosis.

O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP.

Annu Rev Immunol. 2013;31:475-527. doi: 10.1146/annurev-immunol-032712-095939. Review.

PMID:
23516984
43.

Case of the month. Foreign body.

Bloom C, Chang B.

JAAPA. 2013 Feb;26(2):70. No abstract available.

PMID:
23409393
44.

Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virus.

Carter DM, Bloom CE, Nascimento EJ, Marques ET, Craigo JK, Cherry JL, Lipman DJ, Ross TM.

J Virol. 2013 Feb;87(3):1400-10. doi: 10.1128/JVI.02257-12. Epub 2012 Oct 31.

45.

Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy.

Bloom CI, Graham CM, Berry MP, Wilkinson KA, Oni T, Rozakeas F, Xu Z, Rossello-Urgell J, Chaussabel D, Banchereau J, Pascual V, Lipman M, Wilkinson RJ, O'Garra A.

PLoS One. 2012;7(10):e46191. doi: 10.1371/journal.pone.0046191. Epub 2012 Oct 2.

46.

Measuring preschoolers' superstitious tendencies.

Sheehan KJ, Van Reet J, Bloom CM.

Behav Processes. 2012 Oct;91(2):172-6. doi: 10.1016/j.beproc.2012.07.005. Epub 2012 Jul 22.

47.

Complex patterns of human antisera reactivity to novel 2009 H1N1 and historical H1N1 influenza strains.

Carter DM, Lu HR, Bloom CE, Crevar CJ, Cherry JL, Lipman DJ, Ross TM.

PLoS One. 2012;7(7):e39435. doi: 10.1371/journal.pone.0039435. Epub 2012 Jul 17.

48.

Self-injurious behavior vs. nonsuicidal self-injury: the CNS stimulant pemoline as a model of self-destructive behavior.

Bloom CM, Holly S, Miller AM.

Crisis. 2012 Jan 1;33(2):106-12. doi: 10.1027/0227-5910/a000127.

PMID:
22343062
49.

Toward new avenues in the treatment of nonsuicidal self-injury.

Bloom CM, Holly S.

J Pharm Pract. 2011 Oct;24(5):472-7. doi: 10.1177/0897190011422877. Epub 2011 Sep 22. Review.

PMID:
21940603
50.

Polymeric nanoparticles for increased oral bioavailability and rapid absorption using celecoxib as a model of a low-solubility, high-permeability drug.

Morgen M, Bloom C, Beyerinck R, Bello A, Song W, Wilkinson K, Steenwyk R, Shamblin S.

Pharm Res. 2012 Feb;29(2):427-40. doi: 10.1007/s11095-011-0558-7. Epub 2011 Aug 24.

Supplemental Content

Support Center